Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study - PubMed (original) (raw)

Plasma and erythrocyte fatty acid patterns in patients with recurrent depression: a matched case-control study

Johanna Assies et al. PLoS One. 2010.

Abstract

Background: The polyunsaturated fatty acid (PUFA) composition of (nerve) cell membranes may be involved in the pathophysiology of depression. Studies so far, focussed mainly on omega-3 and omega-6 PUFAs. In the present study, saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs) and PUFAs of the omega-3, -6 and -9 series in plasma and erythrocytes of patients with recurrent major depressive disorder (MDD-R) were compared with controls.

Methodology and principal findings: We carried out a case-control study. The sample consisted of 137 patients with MDD-R and 65 matched non-depressed controls. In plasma and erythrocytes of patients with MDD-R the concentrations of most of the SFAs and MUFAs, and additionally erythrocyte PUFAs, all with a chain length > 20 carbon (C) atoms, were significantly lower than in the controls. In contrast, the concentrations of most of the shorter chain members (< or = 18C) of the SFAs and MUFAs were significantly higher in the patients. Estimated activities of several elongases in plasma of patients were significantly altered, whereas delta-9 desaturase activity for C14:0 and C18:0 was significantly higher.

Conclusions/significance: The fatty acid status of patients with MDD-R not only differs with regard to omega-3 and omega-6 PUFAs, but also concerns other fatty acids. These alterations may be due to: differences in diet, changes in synthesizing enzyme activities, higher levels of chronic (oxidative) stress but may also result from adaptive strategies by providing protection against enhanced oxidative stress and production of free radicals.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1

Figure 1. Pathways of fatty acid metabolism.

Due to figure dimension restrictions, the conversion of C16∶0 to C16∶1 ω-7 could not be depicted. Abbreviations used: Elongase (Elo), Desaturase (D).

Similar articles

Cited by

References

    1. Cross-national comparisons of the prevalences and correlates of mental disorders. WHO International Consortium in Psychiatric Epidemiology. Bull World Health Organ. 2000;78:413–426. - PMC - PubMed
    1. Osby U, Brandt L, Correia N, Ekbom A, Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry. 2001;58:844–850. - PubMed
    1. Severus WE, Litmann AB, Stoll AL. Omega 3 fatty acids, homocysteine, and the increased cardiovascular mortality in major depressive disorder. Harv Rev Psychiatry. 2001;9:280–293. - PubMed
    1. Parker G, Gibson NA, Brotchie H, Heruc G, Rees A-M, et al. Omega 3 fatty acids and mood disorders. Am J Psychiatry. 2006;163:969–978. - PubMed
    1. McNamara RK. Evaluation of docosahexaenoic acid deficiency as preventable risk factor for recurrent affective disorders: current status, future directions, and dietary recommendations. Prostaglandins Leukot and Essent Fatty Acids. 2009;81(2–3):223–231. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources